-
Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa
Tuesday, March 31, 2020 - 3:21am | 413The shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as the court ruled against its patent for heart treatment drug Vascepa. What Happened The United States District Court for the District of Nevada in Las Vegas ruled that six patents on Vascepa,...